Glutathione
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00143 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sclerosing cholangitis | KG + DL |
| 2 | myelodysplastic syndrome | KG + DL |
| 3 | unclassified myelodysplastic syndrome | KG + DL |
| 4 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 5 | refractory cytopenia of childhood | KG + DL |
| 6 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 7 | dry eye syndrome | KG + DL |
| 8 | aregenerative anemia | KG + DL |
| 9 | multiple endocrine neoplasia | KG + DL |
| 10 | acne (disease) | KG + DL |
| 11 | bone Paget disease | KG + DL |
| 12 | Sjogren syndrome | KG + DL |
| 13 | seborrheic dermatitis | KG + DL |
| 14 | adrenal gland hyperfunction | KG + DL |
| 15 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 16 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 17 | refractory hematologic cancer | KG + DL |
| 18 | skin disease | KG + DL |
| 19 | prolapse of lacrimal gland | KG + DL |
| 20 | dermatitis | KG + DL |
| 21 | zinc, elevated plasma | KG + DL |
| 22 | diabetic nephropathy | KG + DL |
| 23 | growing teratoma syndrome | KG + DL |
| 24 | Pancoast syndrome | KG + DL |
| 25 | excretory apparatus of the lacrimal system anomaly | KG + DL |
| 26 | Carney triad | KG + DL |
| 27 | severe combined immunodeficiency (disease) | KG + DL |
| 28 | nasolacrimal duct disease | KG + DL |
| 29 | eversion of lacrimal punctum | KG + DL |
| 30 | stenosis of lacrimal sac | KG + DL |
| 31 | lacrimal passage granuloma | KG + DL |
| 32 | secretory apparatus of the lacrimal system anomaly | KG + DL |
| 33 | lacrimal atrophy | KG + DL |
| 34 | anomaly of the secretory and excretory apparatus of the lacrimal system | KG + DL |
| 35 | hypoalphalipoproteinemia | KG + DL |
| 36 | excessive tearing | KG + DL |
| 37 | disorder of lacrimal gland | KG + DL |
| 38 | sebaceous gland anomaly | KG + DL |
| 39 | non-severe combined immunodeficiency | KG + DL |
| 40 | reticulate pigment disorder | KG + DL |
| 41 | Immunoerythromyeloid hypoplasia | KG + DL |
| 42 | severe dermatitis-multiple allergies-metabolic wasting syndrome | KG + DL |
| 43 | erythema palmare hereditarium | KG + DL |
| 44 | granulomatous disease, chronic, autosomal recessive | KG + DL |
| 45 | seborrheic keratosis | KG + DL |
| 46 | hereditary poikiloderma | KG + DL |
| 47 | homozygous familial hypercholesterolemia | KG + DL |
| 48 | multiple benign circumferential skin creases on limbs | KG + DL |
| 49 | scleredema adultorum | KG + DL |
| 50 | diffuse cutaneous mucinosis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.